Prognostic value of miR‑339‑5p in patients with prostate cancer and its effects on tumor progression

Huafeng Pan(University of Chinese Academy of Sciences), Yudi Zhu(University of Chinese Academy of Sciences), Siliang Shao(University of Chinese Academy of Sciences), Rui Xin(Qingdao University of Science and Technology), Wei Wei(Zhujiang Hospital)
Experimental and Therapeutic Medicine
February 24, 2021
10.3892/etm.2021.9821
Cited by 7

Related Papers

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
|Journal of Clinical Oncology|2020|217
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma
|Therapeutic Advances in Medical Oncology|2021|216
Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety
|癌症：英文版|2018|189
A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome
|European Journal of Endocrinology|2011|160